- Home
- RNAZ vs FGI Comparison
RNAZ vs FGI Comparison
Compare RNAZ & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | FGI |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | 420 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAZ | FGI |
|---|---|---|
| Price | $8.73 | $4.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.9K | 20.8K |
| Earning Date | 04-15-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.38 |
| Revenue Next Year | N/A | $6.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.82 | $0.74 |
| 52 Week High | $20.99 | $12.62 |
Technical Indicators
Market Signals| Indicator | RNAZ | FGI |
|---|---|---|
| Relative Strength Index (RSI) | 61.39 | 42.55 |
| Support Level | $8.38 | $3.30 |
| Resistance Level | $9.93 | $5.37 |
| Average True Range (ATR) | 1.21 | 0.42 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 66.97 | 41.47 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.